
CAS 1116745-06-2
:Formel:C26H26ClN3O3
InChl:InChI=1S/C26H26ClN3O3/c1-29(2)9-10-33-18-7-8-21-16(11-18)12-22(28-21)26(32)30-15-17(14-27)25-20-6-4-3-5-19(20)24(31)13-23(25)30/h3-8,11-13,17,28,31H,9-10,14-15H2,1-2H3/t17-/m1/s1
InChI Key:JRGWJJXUVWWGDA-QGZVFWFLSA-N
SMILES:CN(C)CCOC1=CC2=C(C=C1)NC(=C2)C(=O)N3C[C@H](C4=C3C=C(C5=CC=CC=C54)O)CCl
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
5 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Duocarmycin DM free base
CAS:Duocarmycin DM free base is a DNA alkylator; potent antitumor antibiotic; binds DNA minor groove; ADC payload; cancer research.Formel:C26H26ClN3O3Reinheit:95.01%Farbe und Form:SolidMolekulargewicht:463.956Duocarmycin DM
CAS:Kontrolliertes ProduktDuocarmycin DM is an anticancer drug that selectively targets cancer cells and induces apoptosis. It works by binding to the minor groove of DNA and forming a covalent bond with adenine, which leads to DNA damage and ultimately cell death. Duocarmycin DM has been shown to be effective against a variety of human cancer cell lines, including those resistant to other chemotherapeutic agents. This drug also inhibits kinases involved in tumor growth and angiogenesis, making it a promising candidate for cancer therapy. Duocarmycin DM has been studied as an analog to artesunate and chloroquine in Chinese patients with cancer. Inhibitors of this drug have been identified in urine samples from patients receiving treatment, indicating its potential as a therapeutic agent for the treatment of cancer.Formel:C26H26ClN3O3Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:464 g/mol





